Skip to main navigation
Skip to search
Skip to main content
Bar-Ilan University Home
Help & FAQ
Home
Researchers
Organisations
Research output
Prizes
Student theses
Activities
Projects
Press/Media
Datasets
Equipment
Search by expertise, name or affiliation
Pulmonary sarcoidosis associated with etanercept therapy
Raymond E. Farah, Moshe D. Shay
Western Galilee Medical Center of Nahariya
Research output
:
Contribution to journal
›
Article
›
peer-review
36
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pulmonary sarcoidosis associated with etanercept therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pulmonary Sarcoidosis
100%
Etanercept
100%
Sarcoidosis
54%
Psoriatic Arthritis
18%
Illness
9%
Older Men
9%
Adverse Reactions
9%
Lung
9%
40 Years Old
9%
Prednisone
9%
Medical Literature
9%
Granuloma
9%
Corticosteroids
9%
Dyspnea
9%
Respiratory Symptoms
9%
Chest Radiography
9%
Start of Treatment
9%
Pulmonary Disease
9%
Patient Symptoms
9%
Likelihood Score
9%
Naranjo Adverse Drug Reaction Probability Scale
9%
Skin Sarcoidosis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Sarcoidosis
100%
Etanercept
100%
Sarcoidosis
45%
Symptom
18%
Disease
18%
Psoriatic Arthritis
18%
Adverse Drug Reaction
9%
Adverse Event
9%
Lung Disease
9%
Skin Sarcoidosis
9%
Dyspnea
9%
Granuloma
9%
Prednisone
9%